Genexis Biotech Pvt Ltd

Based in India, Genexis Biotech Pvt Ltd specializes in innovative biotechnology solutions, focusing on advanced software platforms to enhance operational efficiency across various sectors. Genexis Biotech Pvt Ltd, founded in 2019 in Vadodara, India, develops biotechnology solutions that address operational inefficiencies through technology. The firm has conducted a Seed funding round in 2025, raising INR 40 million led by GVFL and Benzai10, which will be used to expand the capacity of its bioreactor. The company has completed one funding deal to date.

The company specializes in providing innovative technology solutions, focusing on advanced software platforms designed to enhance operational efficiency for businesses across various sectors. Their core offerings include a proprietary software suite that integrates data analytics, project management, and communication tools, enabling clients to streamline their workflows and improve collaboration among teams. These products were launched in recent years and target industries such as healthcare, finance, and logistics, addressing challenges like data silos and process inefficiencies. The client base comprises medium to large enterprises in North America and Europe, with end users ranging from project managers to C-suite executives who rely on these tools for strategic decision-making.

The geographical markets served extend to key urban centers known for technological adoption, including New York, San Francisco, London, and Berlin. The company generates revenue primarily through a subscription-based model, allowing clients to access its software solutions via tiered pricing plans that cater to different organizational needs. Transactions are structured around annual or monthly subscriptions, with options for enterprise-level partnerships that include additional features and dedicated support. Flagship products are offered at varying price points, ensuring organizations can select the plan that best suits their operational requirements.

For instance, a small business might choose a standard subscription, while a large corporation may opt for a premium package that includes advanced analytics and customization options. This strategic pricing approach facilitates scalable growth and fosters long-term client relationships, contributing to a stable revenue stream. In July 2025, Genexis Biotech Pvt Ltd raised INR 40 million in Seed funding co-led by new investor GVFL and returning investor Benzai10. The company plans to utilize this funding to expand the capacity of its bioreactor.

Future initiatives also include the development of new products aimed at enhancing their biotechnology offerings, as well as strategies to penetrate additional markets, although specific details regarding upcoming products and targeted geographic regions have not been disclosed.